| 摘要 |
<p>Methods and implant materials are provided for treating urinary incontinence. The methods may include providing a composition that includes at least one pharmaceutically active formulation capable of retropubic fat dissolution; and introducing the composition into the retropubic space, preferably via a minimally invasive procedure, to contact adjacent tissue and promote dissolution of retropubic fat therein and consequent induction of adhesions. The implant material for treating urinary incontinence may include at least one pharmaceutically active detergent for promoting retropubic fat dissolution; and a biodegradable carrier material, wherein the implant material is sized and shaped for placement within a patient's retropubic space. The implant material may further include an auxiliary adhesion-promoting material.</p> |
